Dados B3 › BRAP4
BRAP4 (Bradespar): has profit grown?
BRAP4 (Bradespar): in 2023, net income attributable to controlling shareholders was R$ 1.9 billion, down 49% versus 2022 (a profit of R$ 3.7 billion); five years earlier (2018), a profit of R$ 1.2 billion.
| Year | Profit (loss) | Change |
|---|---|---|
| 2023 | R$ 1.9 billion | down 49% |
| 2022 | R$ 3.7 billion | down 54% |
| 2021 | R$ 8.1 billion | up 451% |
| 2020 | R$ 1.5 billion | a turn from loss to profit |
| 2019 | -R$ 403.2 million | a turn from profit to loss |
| 2018 | R$ 1.2 billion | down 49% |
| 2017 | R$ 2.3 billion | up 270% |
| 2016 | R$ 629.3 million | a turn from loss to profit |
| 2015 | -R$ 2.6 billion | a turn from profit to loss |
| 2014 | R$ 101.5 million | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/BRAP4/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: BRAP4.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:11 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:11 UTC. If this does not match /saude, you are reading a cached copy.